Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$929,959
+$765,400 QoQ
Shares Held
387,483
+267.3% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Derivatives in LXRX
reported options exposure · as of Mar 31, 2020CallValue
$1,950
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. LXRX ranks #122 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in LXRX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $929,959 | 387,483 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $164,559 | 105,487 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $223,954 | 194,743 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $43,013 | 31,862 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $30,656 | 32,270 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $67,192 | 146,071 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $180,053 | 243,316 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $304,380 | 193,873 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $66,254 | 39,437 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $155,085 | 64,619 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $194,334 | 127,016 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $42,716 | 39,189 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $86,262 | 37,669 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $102,779 | 42,296 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $42,707 | 22,360 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $8,474 | 3,531 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $139,972 | 75,254 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $173,965 | 83,237 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $334,781 | 84,970 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $133,462 | 27,747 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $60,817 | 13,250 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $244,356 | 41,628 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $45,758 | 13,380 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $27,588 | 19,159 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $286,058 | 143,029 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $137,434 | 70,479 | Shares | Sole | 2020-05-13 | |
| 2020-03-31 | $1,950 | 1,000 | Call | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||